- Home
- GMS vs MLTX Comparison
GMS vs MLTX Comparison
Compare GMS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMS
- MLTX
- Stock Information
- Founded
- GMS 1971
- MLTX 2021
- Country
- GMS United States
- MLTX Switzerland
- Employees
- GMS N/A
- MLTX N/A
- Industry
- GMS
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- GMS
- MLTX Health Care
- Exchange
- GMS Nasdaq
- MLTX Nasdaq
- Market Cap
- GMS N/A
- MLTX 2.3B
- IPO Year
- GMS 2016
- MLTX N/A
- Fundamental
- Price
- GMS $75.53
- MLTX $39.74
- Analyst Decision
- GMS Hold
- MLTX Strong Buy
- Analyst Count
- GMS 7
- MLTX 8
- Target Price
- GMS $80.57
- MLTX $80.50
- AVG Volume (30 Days)
- GMS 295.3K
- MLTX 425.4K
- Earning Date
- GMS 06-20-2025
- MLTX 05-20-2025
- Dividend Yield
- GMS N/A
- MLTX N/A
- EPS Growth
- GMS N/A
- MLTX N/A
- EPS
- GMS 3.66
- MLTX N/A
- Revenue
- GMS $5,592,971,000.00
- MLTX N/A
- Revenue This Year
- GMS $0.80
- MLTX $103.42
- Revenue Next Year
- GMS $0.63
- MLTX N/A
- P/E Ratio
- GMS $19.96
- MLTX N/A
- Revenue Growth
- GMS 3.71
- MLTX N/A
- 52 Week Low
- GMS $65.77
- MLTX $31.42
- 52 Week High
- GMS $105.54
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- GMS 57.18
- MLTX 51.51
- Support Level
- GMS $71.64
- MLTX $39.86
- Resistance Level
- GMS $75.34
- MLTX $42.90
- Average True Range (ATR)
- GMS 1.85
- MLTX 2.15
- MACD
- GMS 0.37
- MLTX 0.03
- Stochastic Oscillator
- GMS 85.08
- MLTX 48.60
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.